Correspondence 0001213900-23-098317 from Bluejay Diagnostics, Inc. (BJDX)
Bluejay Diagnostics, Inc.
Date: Dec. 22, 2023 · CIK: 0001704287 · Accession: 0001213900-23-098317
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-275697
Letter
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue, Suite 203
Acton, MA 01720
December 22, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Bluejay Diagnostics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-275697
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1, as amended (the “Registration Statement”), and declare the Registration Statement effective as of 5:15 p.m., Eastern Time, on December 27, 2023, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The Company hereby authorizes Brian O’Fahey of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf.
Please feel free to direct any questions or comments concerning this request to Mr. O’Fahey at (202) 637-6541, and once the Registration Statement has been declared effective, please notify Mr. O’Fahey by calling him at the same phone number.
Very truly yours,
Bluejay Diagnostics, Inc.
Show Raw Text
CORRESP
1
filename1.htm
Bluejay Diagnostics, Inc.
360 Massachusetts Avenue, Suite 203
Acton, MA 01720
December 22, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Bluejay Diagnostics, Inc.
Registration Statement on Form S-1, as amended
File No. 333-275697
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and
Regulations under the Securities Act of 1933, as amended, Bluejay Diagnostics, Inc. (the “Company”) hereby requests
that the Securities and Exchange Commission accelerate the effectiveness of the above-referenced Registration Statement on Form S-1, as
amended (the “Registration Statement”), and declare the Registration Statement effective as of 5:15 p.m., Eastern Time,
on December 27, 2023, or as soon thereafter as is practicable, or at such other time as the Company may orally request by telephone. The
Company hereby authorizes Brian O’Fahey of Hogan Lovells US LLP, counsel to the Company, to make such request on its behalf.
Please feel free to direct any questions or comments
concerning this request to Mr. O’Fahey at (202) 637-6541, and once the Registration Statement has been declared effective,
please notify Mr. O’Fahey by calling him at the same phone number.
Very truly yours,
Bluejay Diagnostics, Inc.
/s/ Neil Dey
By:
Neil Dey
Title:
President and Chief Executive Officer